The Obesity and Metabolic Surgery Society of India and the Endocrine Society of India jointly published the Expert Consensus on Obesity Management Protocols in Obesity Surgery, establishing 55 clinical recommendations across 78 specialists to shift treatment toward personalized, stigma-free chronic disease care.
Moving Beyond Blame and Stigma in Clinical Practice
Medical guidelines now formally classify obesity as a chronic disease rather than a failure of willpower, according to the joint consensus developed by the Obesity and Metabolic Surgery Society of India (OSSI) and the Endocrine Society of India (ESI). Published on August 3, 2026, the framework brings together 78 experts to establish 55 distinct recommendations covering prevention, diagnosis, lifestyle interventions, medications, metabolic and bariatric surgery, and long-term care.
Experts emphasize that the condition stems from complex genetic, metabolic, endocrine, environmental, psychological, and socioeconomic factors. Consequently, the document urges physicians to adopt a compassionate, evidence-based approach that eliminates weight-related stigma and integrates obesity management more effectively into national health programs.
Did you know? The new OSSI–ESI consensus explicitly states that treatment should focus on improving overall health and quality of life rather than merely reducing body weight.
Why BMI Alone Fails Patient Assessment
Standard body mass index thresholds often fail to capture true health risks in South Asian populations, prompting the new guidelines to advise against relying on BMI or body weight alone to guide treatment decisions. Because Indians frequently develop metabolic complications at lower BMI levels, the consensus directs doctors to evaluate concurrent conditions such as diabetes, fatty liver disease, sleep apnea, and cardiovascular risk.
Timely intervention remains a core pillar of the new protocols. Because the condition is progressive and capable of triggering severe medical complications, the expert panel stresses that waiting for advanced disease stages before initiating structured care compromises long-term patient outcomes.
Tailoring Interventions to Disease Severity
While healthy eating and regular physical activity remain foundational, the framework dictates that treatment plans must be customized based on individual patient needs and disease severity. Depending on clinical assessment, therapeutic options may incorporate psychological support, targeted obesity medications, endoscopic therapies, and metabolic or bariatric surgery.
By providing doctors and policymakers with an India-specific framework, the OSSI and ESI hope to standardize equitable access to modern interventions while shifting the paradigm of metabolic healthcare nationwide.
Frequently Asked Questions
What is the new OSSI–ESI consensus on obesity?
Published on August 3, 2026, in Obesity Surgery, it is a joint guideline developed by 78 experts from the Obesity and Metabolic Surgery Society of India and the Endocrine Society of India featuring 55 recommendations for comprehensive obesity care.
Why should doctors look beyond BMI when treating patients in India?
Indians often develop metabolic complications, including diabetes and fatty liver disease, at lower BMI thresholds, making a broader health assessment necessary.
What treatment options are included in the guidelines?
Depending on individual severity, options include lifestyle interventions, psychological support, anti-obesity medications, endoscopic therapies, and metabolic or bariatric surgery.
Join the Conversation
How should healthcare providers better integrate stigma-free obesity care into daily practice? Share your perspective in the comments below or subscribe to our newsletter for updates on metabolic health research.
Keep reading